Tag: relapsed or refractory b-cell malignancies

$#VisualAbstract: Odronextamab shows promising clinical activity in patients with relapsed or refractory B-cell non-Hodgkin lymphoma$

#VisualAbstract: Odronextamab shows promising clinical activity in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

byKathleen Lau

April 23, 2022

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result